St. James's Hospital is a teaching hospital in Dublin, Ireland. Its academic partner is Trinity College Dublin. It is managed by Dublin Midlands Hospital Group.

There are 1,010 beds in St James's Hospital.

During the past decade, St James's Hospital conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 45 clinical trials were completed, i.e. on average, 44.6% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 26 clinical trials were completed. i.e. 55.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St James's Hospital" #1 sponsor was "Cancer Trials Ireland" with 29 trials, followed by "University of Dublin, Trinity College" with 9 trials sponsored, "Boehringer Ingelheim" with 8 trials sponsored, "Pfizer" with 8 trials sponsored and "St. James's Hospital, Ireland" with 8 trials sponsored. Other sponsors include 125 different institutions and companies that sponsored additional 89 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St James's Hospital" #1 collaborator was "Cancer Trials Ireland" with 6 trials as a collaborator, "Hoffmann-La Roche" with 5 trials as a collaborator, "St. James's Hospital, Ireland" with 5 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials as a collaborator and "University College Dublin" with 4 trials as a collaborator. Other collaborators include 174 different institutions and companies that were collaborators in the rest 154 trials.

According to Clinical.Site data, the most researched conditions in "St James's Hospital" are "Breast Cancer" (17 trials), "Multiple Myeloma" (6 trials), "Ovarian Cancer" (6 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials) and "Fallopian Tube Cancer" (4 trials). Many other conditions were trialed in "St James's Hospital" in a lesser frequency.

Most popular intervention types in "St James's Hospital" are "Drug" (114 trials), "Other" (37 trials), "Biological" (17 trials), "Procedure" (16 trials) and "Device" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Docetaxel" (7 trials), "Carboplatin" (6 trials), "Dexamethasone" (6 trials) and "Bortezomib" (5 trials). Other intervention names were less common.

The vast majority of trials in "St James's Hospital" are 140 trials for "All" genders, 41 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are 60 active trials in "St James's Hospital". 2 are not yet recruiting, 25 are recruiting, 30 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 94 completed trials in St James's Hospital, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in St James's Hospital, 8 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 32 trials that are defined as “Not Applicable".

St James's Hospital has several departments that took part in Clinical trials: "St. James Hospital; Oncology" - 7 trials, "Department of Surgery, St. James's Hospital" - 5 trials, "St James' Hospital; Cancer Clinical Trials Office" - 4 trials